Reaktionsgleichung
[CH3:1][NH:2][S:3]([C:6]1[CH:7]=[C:8]2[C:12](=[CH:13][CH:14]=1)[NH:11][C:10](=[O:15])[CH2:9]2)(=[O:5])=[O:4].[CH3:16][N:17]([CH3:32])[CH2:18][CH2:19][CH2:20][C:21]1[C:29]2[C:24](=[CH:25][CH:26]=[CH:27][CH:28]=2)[NH:23][C:22]=1[CH:30]=O>>[CH3:1][NH:2][S:3]([C:6]1[CH:7]=[C:8]2[C:12](=[CH:13][CH:14]=1)[NH:11][C:10](=[O:15])[C:9]2=[CH:30][C:22]1[NH:23][C:24]2[C:29]([C:21]=1[CH2:20][CH2:19][CH2:18][N:17]([CH3:32])[CH3:16])=[CH:28][CH:27]=[CH:26][CH:25]=2)(=[O:5])=[O:4]Komponenten
3
Versuchsvorschrift
2-Oxo-2,3-dihydro-1H-indole-5-sulfonic acid methylamide (98 mg, 0.43 mmol) was condensed with 3-(3-dimethylamino-propyl)-1H-indole-2-carbaldehyde (100 mg) to give the title compound as an orange solid.
Quellen und Nachweise
- ORD-Eintrag
- ord-3fd925ca572443b2b145ccfec4f9d2a2
- Quelldatensatz
- uspto-grants-2005_02
- Patentnummer
- US06855730B2
Verknüpfte Notizen
Wird geladen…